GPP
ALIM

Great Point Partners’s Alimera Sciences ALIM Stock Holding History

Great Point Partners’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-152,912
Closed -$2.48M – 45
2016
Q4 		$2.48M Sell
152,912
-22,953
-13% -$420K 0.51% 29
2016
Q3 		$3.93M Buy
+175,865
New +$4.05M 1% 20
2015
Q4 		– Sell
-112,211
Closed -$3.72M – 27
2015
Q3 		$3.72M Hold
112,211
– – 1.47% 23
2015
Q2 		$7.76M Sell
112,211
-3,226
-3% -$223K 3.02% 10
2015
Q1 		$8.68M Sell
115,437
-59,220
-34% -$4.66M 3.82% 7
2014
Q4 		$14.5M Hold
174,657
– – 6.99% 3
2014
Q3 		$14.2M Buy
174,657
+67,303
+63% +$5.75M 6.1% 4
2014
Q2 		$9.63M Buy
107,354
+7,354
+7% +$653K 4.28% 9
2014
Q1 		$11.8M Buy
+100,000
New +$9.71M 6.18% 4

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Great Point Partners's ALIM Position: Q1 2017 in Review

Great Point Partners sold out of Alimera Sciences (ALIM) in Q1 2017, closing a stake of 152,912 shares — an estimated $2.48M sold.

Great Point Partners first reported a position in ALIM in Q1 2014 and held it in 9 quarters. The position peaked at $14.5M in Q4 2014. 39 funds tracked by Wall St. Rank hold ALIM as of Q1 2017.

  • Great Point Partners reported no remaining Alimera Sciences position as of Q1 2017 after selling out during the quarter.
  • Great Point Partners sold 152,912 Alimera Sciences shares in Q1 2017, an estimated $2.48M.
  • Great Point Partners first reported a position in Alimera Sciences in Q1 2014 and held it in 9 quarters.
  • Great Point Partners's Alimera Sciences position peaked at $14.5M in Q4 2014.
  • 39 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2017.

Based on Great Point Partners's 13F filing for Q1 2017, filed 15 May 2017.